Home LiteratureArticle Details
PMID: 19038766 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Review

The cell of origin of ovarian epithelial tumours.

The Lancet. Oncology ·Vol. 9 ·No. 12 ·2008-12-00 ·Pages 1191-7

Dubeau L

Abstract

Although it is widely believed that ovarian epithelial tumours arise in the coelomic epithelium that covers the ovarian surface, it has been suggested that they could instead arise from tissues that are embryologically derived from the Müllerian ducts. This article revisits this debate by discussing recent epidemiological and molecular biological findings as well as evidence based on histopathological observations of surgical specimens from individuals with familial ovarian cancer predisposition. Morphological, embryological, and molecular biological characteristics of ovarian epithelial tumours that must be accounted for in formulating a theory about their cell of origin are reviewed, followed by comments about the ability of these two hypotheses to account for each of these characteristics. An argument is made that primary ovarian epithelial tumours, fallopian tube carcinomas, and primary peritoneal carcinomas are all Müllerian in nature and could therefore be regarded as a single disease entity. Although a substantial proportion of cancers currently regarded as of primary ovarian origin arise in the fimbriated end of the fallopian tube, this site cannot account for all of these tumours, some of which are most likely derived from components of the secondary Müllerian system.

MeSH Terms
Animals Carcinoma/pathology Cystadenoma, Serous/pathology Fallopian Tubes/pathology Female Humans Mullerian Ducts/pathology Neoplasms, Glandular and Epithelial/pathology Ovarian Neoplasms/pathology
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Dubeau Louis
Department of Pathology, Keck School of Medicine of USC, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
References (42)
42 references, click to expand
  1. Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases.
    Cancer. 1989 Jul 1;64(1):110-5 PMID: 2731107
  2. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    JAMA. 2006 Jul 12;296(2):185-92 PMID: 16835424
  3. Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells.
    Curr Biol. 2005 Mar 29;15(6):561-5 PMID: 15797026
  4. Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up.
    Br J Obstet Gynaecol. 1997 Nov;104(11):1296-301 PMID: 9386032
  5. Pathologic findings in prophylactic oophorectomy specimens in high-risk women.
    Gynecol Oncol. 2002 Oct;87(1):52-6 PMID: 12468342
  6. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
    Nat Med. 1996 Nov;2(11):1179-83 PMID: 8898735
  7. Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer?
    Am J Epidemiol. 1986 Nov;124(5):856-8 PMID: 3766518
  8. Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status.
    Am J Surg Pathol. 2001 Oct;25(10):1283-9 PMID: 11688463
  9. Benign and malignant serous and endometrioid epithelium in the omentum.
    Gynecol Oncol. 1999 Nov;75(2):227-32 PMID: 10525377
  10. Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer.
    Ann Epidemiol. 1995 Jul;5(4):310-4 PMID: 8520714
  11. Cancer risk after a hospital discharge diagnosis of endometriosis.
    Am J Obstet Gynecol. 1997 Mar;176(3):572-9 PMID: 9077609
  12. Serous cystadenoma formation in guinea pig ovaries.
    J Submicrosc Cytol. 1981 Jul;13(3):337-45 PMID: 7334540
  13. Possible role of ovarian epithelial inflammation in ovarian cancer.
    J Natl Cancer Inst. 1999 Sep 1;91(17):1459-67 PMID: 10469746
  14. Müllerian-inhibiting substance function during mammalian sexual development.
    Cell. 1994 Nov 4;79(3):415-25 PMID: 7954809
  15. Papillary serous carcinoma of the peritoneum.
    Obstet Gynecol. 1990 Jan;75(1):89-95 PMID: 2296429
  16. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
    J Pathol. 2001 Nov;195(4):451-6 PMID: 11745677
  17. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group.
    Int J Cancer. 1997 Jun 11;71(6):948-51 PMID: 9185694
  18. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer.
    Am J Epidemiol. 1991 Aug 15;134(4):362-9 PMID: 1877597
  19. Epithelial abnormalities in cystic ovarian endometriosis.
    Gynecol Oncol. 2002 Feb;84(2):280-4 PMID: 11812087
  20. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
    Br J Cancer. 2004 Apr 19;90(8):1492-7 PMID: 15083174
  21. Cysts (cystadenomas) and tumors of the rete ovarii.
    Int J Gynecol Pathol. 1988;7(4):330-42 PMID: 2852648
  22. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification.
    Cancer Res. 1991 Aug 1;51(15):4045-51 PMID: 1677312
  23. Endometriosis: novel etiopathogenetic concepts and clinical perspectives.
    Fertil Steril. 2002 Oct;78(4):665-78 PMID: 12372439
  24. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.
    J Clin Oncol. 2003 Nov 15;21(22):4222-7 PMID: 14615451
  25. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
    Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):933-5 PMID: 8922304
  26. Malignant neoplasms arising in endometriosis.
    Obstet Gynecol. 1990 Jun;75(6):1023-8 PMID: 2188180
  27. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract.
    Nat Med. 2005 May;11(5):531-7 PMID: 15821746
  28. Tubal ligation and fatal ovarian cancer in a large prospective cohort study.
    Am J Epidemiol. 1997 Feb 15;145(4):349-57 PMID: 9054239
  29. Endometriosis and ovarian cancer: thoughts on shared pathophysiology.
    Am J Obstet Gynecol. 2003 Jul;189(1):280-94 PMID: 12861175
  30. Tubal ligation and the risk of ovarian carcinoma.
    Cancer Detect Prev. 1997;21(1):1-6 PMID: 9043756
  31. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?
    Gynecol Oncol. 1999 Mar;72(3):437-42 PMID: 10053122
  32. Does the rete ovarii act as a trigger for the onset of meiosis?
    Nature. 1974 Nov 29;252(5482):396-7 PMID: 4431461
  33. The secondary müllerian system revisited.
    Int J Gynecol Pathol. 1994 Jan;13(1):73-9 PMID: 8112958
  34. The distal fallopian tube: a new model for pelvic serous carcinogenesis.
    Curr Opin Obstet Gynecol. 2007 Feb;19(1):3-9 PMID: 17218844
  35. Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).
    Gynecol Oncol. 1995 Dec;59(3):394-7 PMID: 8522262
  36. Ovarian tumor development: insights from ovarian embryogenesis.
    Eur J Gynaecol Oncol. 2001;22(3):175-83 PMID: 11501768
  37. Anti-Müllerian hormone and its receptors.
    Mol Cell Endocrinol. 2001 Jun 20;179(1-2):25-32 PMID: 11420127
  38. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study.
    JAMA. 1993 Dec 15;270(23):2813-8 PMID: 8133619
  39. Multiple focal extraovarian serous carcinoma.
    Int J Gynecol Pathol. 1985;4(1):11-23 PMID: 3880151
  40. Surgical procedures associated with risk of ovarian cancer.
    Int J Epidemiol. 1997 Aug;26(4):710-5 PMID: 9279601
  41. Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects.
    Gynecol Oncol. 1991 Mar;40(3):230-6 PMID: 2013445
  42. Pathology of ovarian cancer precursors.
    J Cell Biochem Suppl. 1995;23:208-18 PMID: 8747398
Article Info
Journal
The Lancet. Oncology
Abbr.
Lancet Oncol
ISSN
1474-5488
Published
2008-12-00
Pages
1191-7
Language
English
Region
England
NLM ID
100957246
PMCID
PMC4176875
Subset
IM
Grants
NCI NIH HHS · R01 CA119078 · United States
NCI NIH HHS · R01CA119078 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com